Approval · Notice of Compliance 6080 · 2002
NUFLOR INJECTABLE SOLUTION: Notice of Compliance 6080
Issued July 5, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6080
- Date
- July 5, 2002
- Company
- Schering Canada Inc.
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of bovine interdigital phlegmon (foot rot, interdigital necrobacillosis, infectious pododermatitis) associated with fusobacterium necrophorum and bacteroides melaninogenicus
- Therapeutic class
- Antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUFLOR INJECTABLE SOLUTION | 02216558 | Marketed |
Medicinal ingredients
- FLORFENICOL 300 MG per ML